Lineage Cell Therapeutics, Inc.
Ticker: 876343
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 1.43+33.6% | 1.07-38.2% | 1.73-53.0% | 3.68+32.9% | 2.77+84.7% | 1.50-60.3% | 3.78+168.1% | 1.41 |
| Total Income | 1.43+33.6% | 1.07-38.2% | 1.73-53.0% | 3.68+32.9% | 2.77+84.7% | 1.50-60.3% | 3.78+168.1% | 1.41 |
| EXPENSES | ||||||||
| Expenditure | 8.75-12.4% | 9.99+7.2% | 9.32+24.8% | 7.47-66.9% | 22.55+181.5% | 8.01+5.1% | 7.62+4.7% | 7.28 |
| Tax | 0.48 | — | — | — | — | — | 0.00 | 0.00 |
| PROFIT | ||||||||
| PBT | 4.71 | — | — | — | — | — | -3.00+48.0% | -5.77 |
| Net Profit | 4.23+185.8% | 1.48+130.8% | -4.81+83.8% | -29.78+2.2% | -30.46-635.7% | -4.14-36.6% | -3.03+47.4% | -5.76 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | 100.00% | 100.00%+200.00pp | -100.00% | -100.00% | -100.00% | -100.00%-19.71pp | -80.29%+19.71pp | -100.00% |
| EPS | 0.02+100.0% | 0.01+150.0% | -0.02+84.6% | -0.13+0.0% | -0.13-550.0% | -0.02+0.0% | -0.02+33.3% | -0.03 |
Corporate Events
Board MeetingLCTX
202610Jun
Board Meeting
Annual meeting of shareholders to elect directors, ratify th…
SEC Filing ↗